These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31782825)

  • 1. Folic acid-conjugated raloxifene hydrochloride carbon nanotube for targeting breast cancer cells.
    Jawahar N; De A; Jubee S; Reddy ES
    Drug Dev Res; 2020 May; 81(3):305-314. PubMed ID: 31782825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: Synthesis, optimisation and in vitro biological evaluation.
    Sinai Kunde S; Wairkar S
    Int J Pharm; 2022 Jul; 623():121926. PubMed ID: 35716974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Assembling Raloxifene Loaded Mixed Micelles: Formulation Optimization, In Vitro Cytotoxicity and In Vivo Pharmacokinetics.
    Kanade R; Boche M; Pokharkar V
    AAPS PharmSciTech; 2018 Apr; 19(3):1105-1115. PubMed ID: 29181706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycopolymer decorated multiwalled carbon nanotubes for dual targeted breast cancer therapy.
    Omurtag Ozgen PS; Atasoy S; Zengin Kurt B; Durmus Z; Yigit G; Dag A
    J Mater Chem B; 2020 Apr; 8(15):3123-3137. PubMed ID: 32211704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells.
    Singh R; Mehra NK; Jain V; Jain NK
    J Drug Target; 2013 Jul; 21(6):581-92. PubMed ID: 23484494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and properties of carbon nanotube (Fe)/hydroxyapatite composite as magnetic targeted drug delivery carrier.
    Li H; Sun X; Li Y; Li B; Liang C; Wang H
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():222-229. PubMed ID: 30678906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-molecule approach to explore binding, uptake and transport of cancer cell targeting nanotubes.
    Lamprecht C; Plochberger B; Ruprecht V; Wieser S; Rankl C; Heister E; Unterauer B; Brameshuber M; Danzberger J; Lukanov P; Flahaut E; Schütz G; Hinterdorfer P; Ebner A
    Nanotechnology; 2014 Mar; 25(12):125704. PubMed ID: 24577143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene.
    Shah P; Rajput SJ
    Drug Dev Ind Pharm; 2019 Apr; 45(4):587-602. PubMed ID: 30633575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of intravaginal rod insert bearing liposomal raloxifene hydrochloride and Leuprolide acetate as a potential carrier for uterine targeting.
    Patel A; Dhande R; Thakkar H
    J Pharm Pharmacol; 2021 Mar; 73(5):653-663. PubMed ID: 33772288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized semisolid self-nanoemulsifying system based on glyceryl behenate: A potential nanoplatform for enhancing antitumor activity of raloxifene hydrochloride in MCF-7 human breast cancer cells.
    Badr-Eldin SM; Aldawsari HM; Ahmed OAA; Alhakamy NA; Neamatallah T; Okbazghi SZ; Fahmy UA
    Int J Pharm; 2021 May; 600():120493. PubMed ID: 33744452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of single-wall carbon nanotube-paclitaxel-folic acid conjugate as an anti-cancer targeting agent.
    Tavakolifard S; Biazar E; Pourshamsian K; Moslemin MH
    Artif Cells Nanomed Biotechnol; 2016 Aug; 44(5):1247-53. PubMed ID: 25783856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.
    Yadav AS; Radharani NNV; Gorain M; Bulbule A; Shetti D; Roy G; Baby T; Kundu GC
    Nanoscale; 2020 May; 12(19):10664-10684. PubMed ID: 32374338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells.
    Kayani Z; Bordbar AK; Firuzi O
    Biomed Pharmacother; 2018 Nov; 107():945-956. PubMed ID: 30257407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid functionalized starch encapsulated green synthesized copper oxide nanoparticles for targeted drug delivery in breast cancer therapy.
    Mariadoss AVA; Saravanakumar K; Sathiyaseelan A; Venkatachalam K; Wang MH
    Int J Biol Macromol; 2020 Dec; 164():2073-2084. PubMed ID: 32784027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
    Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
    Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cationic supersaturable nanomicellar systems of raloxifene hydrochloride with enhanced biopharmaceutical attributes.
    Jain A; Kaur R; Beg S; Kushwah V; Jain S; Singh B
    Drug Deliv Transl Res; 2018 Jun; 8(3):670-692. PubMed ID: 29589250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
    Mehra NK; Jain NK
    J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery.
    Mehra NK; Jain NK
    Mol Pharm; 2015 Feb; 12(2):630-43. PubMed ID: 25517904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
    Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.